Brief: Echoiq Ltd Announces Agreement With Mayo Clinic
24/03/2026 24:29
March 24 (Reuters) - EchoIQ Ltd EIQ.AX: AGREEMENT WITH MAYO CLINIC IN PREPARATION FOR POTENTIAL FDA CLEARANCE OF ECHOSOLV HF AGREEMENT ENABLES MAYO CLINIC TO RESELL AND DISTRIBUTE ECHOSOLV HF FOLLOWING FDA CLEARANCE Further company coverage: EIQ.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on EchoIQ
See all newsAustralia's EchoIQ gains most in nearly 3 months after FDA update
Brief: EchoIQ Says FDA Raises No Concerns About Echosolv HF Technology Or Core Functionality
Australia's EchoIQ heads for worst week in seven years after US FDA setback
Australia's Echo IQ logs worst day in seven years after FDA setback
Brief: EchoIQ Requests Trading Halt